Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2033128rdf:typepubmed:Citationlld:pubmed
pubmed-article:2033128lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2033128lifeskim:mentionsumls-concept:C0023646lld:lifeskim
pubmed-article:2033128lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:2033128lifeskim:mentionsumls-concept:C0332448lld:lifeskim
pubmed-article:2033128lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2033128lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:2033128lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:2033128pubmed:issue4lld:pubmed
pubmed-article:2033128pubmed:dateCreated1991-6-26lld:pubmed
pubmed-article:2033128pubmed:abstractTextWe have investigated immunohistologically the cutaneous immune infiltrate in the lesions of five patients with severe, extensive lichen planus of recent onset before and after 15 days of oral, low-dose cyclosporine therapy (3 mg/kg/day). Before therapy, we observed an abnormal bandlike cellular infiltrate localized in the papillary dermis, composed mostly of CD3+ cells, with a prevalence of CD4+ cells. Infiltrating lymphocytes showed markers of activation (HLA-DR antigens and interleukin 2 receptor), and there were many Langerhans (CD1+) cells in the dermal infiltrate. After 15 days of cyclosporine therapy, we observed a dramatic decrease in the total number of T cells and a corresponding decrease in interleukin 2 receptor-positive activated CD25+ cells and in antigen-presenting cells (CD1+ and CD14b+). These changes were concurrent with clinical improvement. Our results are compatible with the hypothesis that the inhibition of CD4 T cells by cyclosporine might explain the drug's therapeutic action and that the interaction between antigen-presenting cells and CD4 T cells is important in the pathogenesis of lichen planus.lld:pubmed
pubmed-article:2033128pubmed:languageenglld:pubmed
pubmed-article:2033128pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2033128pubmed:citationSubsetIMlld:pubmed
pubmed-article:2033128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2033128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2033128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2033128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2033128pubmed:statusMEDLINElld:pubmed
pubmed-article:2033128pubmed:monthAprlld:pubmed
pubmed-article:2033128pubmed:issn0190-9622lld:pubmed
pubmed-article:2033128pubmed:authorpubmed-author:FinziA FAFlld:pubmed
pubmed-article:2033128pubmed:authorpubmed-author:CattaneoAAlld:pubmed
pubmed-article:2033128pubmed:authorpubmed-author:MozzanicaNNlld:pubmed
pubmed-article:2033128pubmed:authorpubmed-author:PigattoPPlld:pubmed
pubmed-article:2033128pubmed:authorpubmed-author:LegoriAAlld:pubmed
pubmed-article:2033128pubmed:issnTypePrintlld:pubmed
pubmed-article:2033128pubmed:volume24lld:pubmed
pubmed-article:2033128pubmed:ownerNLMlld:pubmed
pubmed-article:2033128pubmed:authorsCompleteYlld:pubmed
pubmed-article:2033128pubmed:pagination550-4lld:pubmed
pubmed-article:2033128pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:meshHeadingpubmed-meshheading:2033128-...lld:pubmed
pubmed-article:2033128pubmed:year1991lld:pubmed
pubmed-article:2033128pubmed:articleTitleImmunohistologic evaluation of the effect of cyclosporine treatment on the lichen planus immune infiltrate.lld:pubmed
pubmed-article:2033128pubmed:affiliationSecond Department of Dermatology, University of Milan, Italy.lld:pubmed
pubmed-article:2033128pubmed:publicationTypeJournal Articlelld:pubmed